Aztreonam compared to chloramphenicol in the treatment of enteric fevers

N. I. Girgis, Z. Farid, M. E. Kilpatrick, John Podgore, Y. Sultan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Fifty-seven patients, twenty-six males and thirty-one females, aged 6 to 50 years (mean 12.6 years) with proven Salmonella typhi or S. paratyphi A septicaemia, were treated in an open randomized parallel study with either aztreonam or chloramphenicol. Aztreonam was given intramuscularly at a level of 50 to 80 mg/kg body weight per dose every 8 h for 7 days to thirty patients. Chloramphenicol was given orally in a dose of 50 to 70 mg/kg body weight every 6 h for 12 days to twenty-seven patients. All patients responded rapidly to treatment, becoming afebrile and asymptomatic within 5.5 to 6.4 days. Only one patient on aztreonam relapsed following treatment, whereas three patients relapsed after chloramphenicol treatment. There were no serious side effects with either drug.

Original languageEnglish
Pages (from-to)197-199
Number of pages3
JournalDrugs under Experimental and Clinical Research
Volume18
Issue number5
StatePublished - 1 Jan 1992

Fingerprint

Aztreonam
Typhoid Fever
Chloramphenicol
Therapeutics
Body Weight
Salmonella typhi
Sepsis
Pharmaceutical Preparations

Cite this

Girgis, N. I. ; Farid, Z. ; Kilpatrick, M. E. ; Podgore, John ; Sultan, Y. / Aztreonam compared to chloramphenicol in the treatment of enteric fevers. In: Drugs under Experimental and Clinical Research. 1992 ; Vol. 18, No. 5. pp. 197-199.
@article{2b8e4852f20447e6a8040a246e978d5e,
title = "Aztreonam compared to chloramphenicol in the treatment of enteric fevers",
abstract = "Fifty-seven patients, twenty-six males and thirty-one females, aged 6 to 50 years (mean 12.6 years) with proven Salmonella typhi or S. paratyphi A septicaemia, were treated in an open randomized parallel study with either aztreonam or chloramphenicol. Aztreonam was given intramuscularly at a level of 50 to 80 mg/kg body weight per dose every 8 h for 7 days to thirty patients. Chloramphenicol was given orally in a dose of 50 to 70 mg/kg body weight every 6 h for 12 days to twenty-seven patients. All patients responded rapidly to treatment, becoming afebrile and asymptomatic within 5.5 to 6.4 days. Only one patient on aztreonam relapsed following treatment, whereas three patients relapsed after chloramphenicol treatment. There were no serious side effects with either drug.",
author = "Girgis, {N. I.} and Z. Farid and Kilpatrick, {M. E.} and John Podgore and Y. Sultan",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "18",
pages = "197--199",
journal = "Drugs under Experimental and Clinical Research",
issn = "0378-6501",
publisher = "Bioscience Ediprint Inc.",
number = "5",

}

Girgis, NI, Farid, Z, Kilpatrick, ME, Podgore, J & Sultan, Y 1992, 'Aztreonam compared to chloramphenicol in the treatment of enteric fevers', Drugs under Experimental and Clinical Research, vol. 18, no. 5, pp. 197-199.

Aztreonam compared to chloramphenicol in the treatment of enteric fevers. / Girgis, N. I.; Farid, Z.; Kilpatrick, M. E.; Podgore, John; Sultan, Y.

In: Drugs under Experimental and Clinical Research, Vol. 18, No. 5, 01.01.1992, p. 197-199.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Aztreonam compared to chloramphenicol in the treatment of enteric fevers

AU - Girgis, N. I.

AU - Farid, Z.

AU - Kilpatrick, M. E.

AU - Podgore, John

AU - Sultan, Y.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Fifty-seven patients, twenty-six males and thirty-one females, aged 6 to 50 years (mean 12.6 years) with proven Salmonella typhi or S. paratyphi A septicaemia, were treated in an open randomized parallel study with either aztreonam or chloramphenicol. Aztreonam was given intramuscularly at a level of 50 to 80 mg/kg body weight per dose every 8 h for 7 days to thirty patients. Chloramphenicol was given orally in a dose of 50 to 70 mg/kg body weight every 6 h for 12 days to twenty-seven patients. All patients responded rapidly to treatment, becoming afebrile and asymptomatic within 5.5 to 6.4 days. Only one patient on aztreonam relapsed following treatment, whereas three patients relapsed after chloramphenicol treatment. There were no serious side effects with either drug.

AB - Fifty-seven patients, twenty-six males and thirty-one females, aged 6 to 50 years (mean 12.6 years) with proven Salmonella typhi or S. paratyphi A septicaemia, were treated in an open randomized parallel study with either aztreonam or chloramphenicol. Aztreonam was given intramuscularly at a level of 50 to 80 mg/kg body weight per dose every 8 h for 7 days to thirty patients. Chloramphenicol was given orally in a dose of 50 to 70 mg/kg body weight every 6 h for 12 days to twenty-seven patients. All patients responded rapidly to treatment, becoming afebrile and asymptomatic within 5.5 to 6.4 days. Only one patient on aztreonam relapsed following treatment, whereas three patients relapsed after chloramphenicol treatment. There were no serious side effects with either drug.

UR - http://www.scopus.com/inward/record.url?scp=0026489286&partnerID=8YFLogxK

M3 - Article

C2 - 1490435

AN - SCOPUS:0026489286

VL - 18

SP - 197

EP - 199

JO - Drugs under Experimental and Clinical Research

JF - Drugs under Experimental and Clinical Research

SN - 0378-6501

IS - 5

ER -